If investors can get over this negative sentiment, then we will...

If investors can get over this negative sentiment, then we will see a retrace in prices. I'm sure this is nothing, but it would be nice if Psvidia gave clearer information on the deal. Once this is made clear this stock will see an + upside

The Age --- Page: B2
Australian-listed biotechnology company, pSivida, has reached an agreement with Pfizer. News of the exclusive $A203 million global collaborative research and licensing deal prompted a 24 per cent rise in pSivida shares on 4 April 2007, to $A0.33. The stock ended trade at $A0.28. However, analysts have expressed reservations about the deal, as Pfizer reserves the right to terminate the agreement without cause on 60 days' notice. pSivida claims the deal will allow it to pay off its outstanding debts.